Global Radiation Oncology Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Radiation Oncology market report explains the definition, types, applications, major countries, and major players of the Radiation Oncology market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • C R Bard

    • iCAD

    • Nordion

    • Mevion Medical Systems

    • Toshiba Medical Systems

    • Varian Medical Systems

    • NTP Radioisotopes

    • Accuray

    • IBA Worldwide

    • IsoRay

    • Elekta

    • Carl Zeiss Meditec

    By Type:

    • External Beam Radiation Therapy (EBRT)

    • Brachytherapy

    By End-User:

    • Blood Cancer (Leukaemia)

    • Breast Cancer

    • Gastrointestinal Cancer

    • Respiratory/Lung Cancer

    • Skin Cancer

    • Other Cancers

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Radiation Oncology Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Radiation Oncology Outlook to 2028- Original Forecasts

    • 2.2 Radiation Oncology Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Radiation Oncology Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Radiation Oncology Market- Recent Developments

    • 6.1 Radiation Oncology Market News and Developments

    • 6.2 Radiation Oncology Market Deals Landscape

    7 Radiation Oncology Raw Materials and Cost Structure Analysis

    • 7.1 Radiation Oncology Key Raw Materials

    • 7.2 Radiation Oncology Price Trend of Key Raw Materials

    • 7.3 Radiation Oncology Key Suppliers of Raw Materials

    • 7.4 Radiation Oncology Market Concentration Rate of Raw Materials

    • 7.5 Radiation Oncology Cost Structure Analysis

      • 7.5.1 Radiation Oncology Raw Materials Analysis

      • 7.5.2 Radiation Oncology Labor Cost Analysis

      • 7.5.3 Radiation Oncology Manufacturing Expenses Analysis

    8 Global Radiation Oncology Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Radiation Oncology Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Radiation Oncology Export by Region (Top 10 Countries) (2017-2028)

    9 Global Radiation Oncology Market Outlook by Types and Applications to 2022

    • 9.1 Global Radiation Oncology Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global External Beam Radiation Therapy (EBRT) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Brachytherapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Radiation Oncology Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Blood Cancer (Leukaemia) Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Respiratory/Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Skin Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Other Cancers Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Radiation Oncology Market Analysis and Outlook till 2022

    • 10.1 Global Radiation Oncology Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Radiation Oncology Consumption (2017-2022)

      • 10.2.2 Canada Radiation Oncology Consumption (2017-2022)

      • 10.2.3 Mexico Radiation Oncology Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Radiation Oncology Consumption (2017-2022)

      • 10.3.2 UK Radiation Oncology Consumption (2017-2022)

      • 10.3.3 Spain Radiation Oncology Consumption (2017-2022)

      • 10.3.4 Belgium Radiation Oncology Consumption (2017-2022)

      • 10.3.5 France Radiation Oncology Consumption (2017-2022)

      • 10.3.6 Italy Radiation Oncology Consumption (2017-2022)

      • 10.3.7 Denmark Radiation Oncology Consumption (2017-2022)

      • 10.3.8 Finland Radiation Oncology Consumption (2017-2022)

      • 10.3.9 Norway Radiation Oncology Consumption (2017-2022)

      • 10.3.10 Sweden Radiation Oncology Consumption (2017-2022)

      • 10.3.11 Poland Radiation Oncology Consumption (2017-2022)

      • 10.3.12 Russia Radiation Oncology Consumption (2017-2022)

      • 10.3.13 Turkey Radiation Oncology Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Radiation Oncology Consumption (2017-2022)

      • 10.4.2 Japan Radiation Oncology Consumption (2017-2022)

      • 10.4.3 India Radiation Oncology Consumption (2017-2022)

      • 10.4.4 South Korea Radiation Oncology Consumption (2017-2022)

      • 10.4.5 Pakistan Radiation Oncology Consumption (2017-2022)

      • 10.4.6 Bangladesh Radiation Oncology Consumption (2017-2022)

      • 10.4.7 Indonesia Radiation Oncology Consumption (2017-2022)

      • 10.4.8 Thailand Radiation Oncology Consumption (2017-2022)

      • 10.4.9 Singapore Radiation Oncology Consumption (2017-2022)

      • 10.4.10 Malaysia Radiation Oncology Consumption (2017-2022)

      • 10.4.11 Philippines Radiation Oncology Consumption (2017-2022)

      • 10.4.12 Vietnam Radiation Oncology Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Radiation Oncology Consumption (2017-2022)

      • 10.5.2 Colombia Radiation Oncology Consumption (2017-2022)

      • 10.5.3 Chile Radiation Oncology Consumption (2017-2022)

      • 10.5.4 Argentina Radiation Oncology Consumption (2017-2022)

      • 10.5.5 Venezuela Radiation Oncology Consumption (2017-2022)

      • 10.5.6 Peru Radiation Oncology Consumption (2017-2022)

      • 10.5.7 Puerto Rico Radiation Oncology Consumption (2017-2022)

      • 10.5.8 Ecuador Radiation Oncology Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Radiation Oncology Consumption (2017-2022)

      • 10.6.2 Kuwait Radiation Oncology Consumption (2017-2022)

      • 10.6.3 Oman Radiation Oncology Consumption (2017-2022)

      • 10.6.4 Qatar Radiation Oncology Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Radiation Oncology Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Radiation Oncology Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Radiation Oncology Consumption (2017-2022)

      • 10.7.2 South Africa Radiation Oncology Consumption (2017-2022)

      • 10.7.3 Egypt Radiation Oncology Consumption (2017-2022)

      • 10.7.4 Algeria Radiation Oncology Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Radiation Oncology Consumption (2017-2022)

      • 10.8.2 New Zealand Radiation Oncology Consumption (2017-2022)

    11 Global Radiation Oncology Competitive Analysis

    • 11.1 C R Bard

      • 11.1.1 C R Bard Company Details

      • 11.1.2 C R Bard Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 C R Bard Radiation Oncology Main Business and Markets Served

      • 11.1.4 C R Bard Radiation Oncology Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 iCAD

      • 11.2.1 iCAD Company Details

      • 11.2.2 iCAD Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 iCAD Radiation Oncology Main Business and Markets Served

      • 11.2.4 iCAD Radiation Oncology Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Nordion

      • 11.3.1 Nordion Company Details

      • 11.3.2 Nordion Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Nordion Radiation Oncology Main Business and Markets Served

      • 11.3.4 Nordion Radiation Oncology Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Mevion Medical Systems

      • 11.4.1 Mevion Medical Systems Company Details

      • 11.4.2 Mevion Medical Systems Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Mevion Medical Systems Radiation Oncology Main Business and Markets Served

      • 11.4.4 Mevion Medical Systems Radiation Oncology Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Toshiba Medical Systems

      • 11.5.1 Toshiba Medical Systems Company Details

      • 11.5.2 Toshiba Medical Systems Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Toshiba Medical Systems Radiation Oncology Main Business and Markets Served

      • 11.5.4 Toshiba Medical Systems Radiation Oncology Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Varian Medical Systems

      • 11.6.1 Varian Medical Systems Company Details

      • 11.6.2 Varian Medical Systems Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Varian Medical Systems Radiation Oncology Main Business and Markets Served

      • 11.6.4 Varian Medical Systems Radiation Oncology Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 NTP Radioisotopes

      • 11.7.1 NTP Radioisotopes Company Details

      • 11.7.2 NTP Radioisotopes Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 NTP Radioisotopes Radiation Oncology Main Business and Markets Served

      • 11.7.4 NTP Radioisotopes Radiation Oncology Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Accuray

      • 11.8.1 Accuray Company Details

      • 11.8.2 Accuray Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Accuray Radiation Oncology Main Business and Markets Served

      • 11.8.4 Accuray Radiation Oncology Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 IBA Worldwide

      • 11.9.1 IBA Worldwide Company Details

      • 11.9.2 IBA Worldwide Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 IBA Worldwide Radiation Oncology Main Business and Markets Served

      • 11.9.4 IBA Worldwide Radiation Oncology Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 IsoRay

      • 11.10.1 IsoRay Company Details

      • 11.10.2 IsoRay Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 IsoRay Radiation Oncology Main Business and Markets Served

      • 11.10.4 IsoRay Radiation Oncology Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Elekta

      • 11.11.1 Elekta Company Details

      • 11.11.2 Elekta Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Elekta Radiation Oncology Main Business and Markets Served

      • 11.11.4 Elekta Radiation Oncology Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Carl Zeiss Meditec

      • 11.12.1 Carl Zeiss Meditec Company Details

      • 11.12.2 Carl Zeiss Meditec Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Carl Zeiss Meditec Radiation Oncology Main Business and Markets Served

      • 11.12.4 Carl Zeiss Meditec Radiation Oncology Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    12 Global Radiation Oncology Market Outlook by Types and Applications to 2028

    • 12.1 Global Radiation Oncology Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global External Beam Radiation Therapy (EBRT) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Brachytherapy Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Radiation Oncology Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Blood Cancer (Leukaemia) Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Respiratory/Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Skin Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Other Cancers Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Radiation Oncology Market Analysis and Outlook to 2028

    • 13.1 Global Radiation Oncology Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Radiation Oncology Consumption Forecast (2022-2028)

      • 13.2.2 Canada Radiation Oncology Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Radiation Oncology Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Radiation Oncology Consumption Forecast (2022-2028)

      • 13.3.2 UK Radiation Oncology Consumption Forecast (2022-2028)

      • 13.3.3 Spain Radiation Oncology Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Radiation Oncology Consumption Forecast (2022-2028)

      • 13.3.5 France Radiation Oncology Consumption Forecast (2022-2028)

      • 13.3.6 Italy Radiation Oncology Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Radiation Oncology Consumption Forecast (2022-2028)

      • 13.3.8 Finland Radiation Oncology Consumption Forecast (2022-2028)

      • 13.3.9 Norway Radiation Oncology Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Radiation Oncology Consumption Forecast (2022-2028)

      • 13.3.11 Poland Radiation Oncology Consumption Forecast (2022-2028)

      • 13.3.12 Russia Radiation Oncology Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Radiation Oncology Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Radiation Oncology Consumption Forecast (2022-2028)

      • 13.4.2 Japan Radiation Oncology Consumption Forecast (2022-2028)

      • 13.4.3 India Radiation Oncology Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Radiation Oncology Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Radiation Oncology Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Radiation Oncology Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Radiation Oncology Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Radiation Oncology Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Radiation Oncology Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Radiation Oncology Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Radiation Oncology Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Radiation Oncology Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Radiation Oncology Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Radiation Oncology Consumption Forecast (2022-2028)

      • 13.5.3 Chile Radiation Oncology Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Radiation Oncology Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Radiation Oncology Consumption Forecast (2022-2028)

      • 13.5.6 Peru Radiation Oncology Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Radiation Oncology Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Radiation Oncology Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Radiation Oncology Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Radiation Oncology Consumption Forecast (2022-2028)

      • 13.6.3 Oman Radiation Oncology Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Radiation Oncology Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Radiation Oncology Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Radiation Oncology Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Radiation Oncology Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Radiation Oncology Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Radiation Oncology Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Radiation Oncology Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Radiation Oncology Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Radiation Oncology Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Radiation Oncology

    • Figure of Radiation Oncology Picture

    • Table Global Radiation Oncology Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Radiation Oncology Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global External Beam Radiation Therapy (EBRT) Consumption and Growth Rate (2017-2022)

    • Figure Global Brachytherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Cancer (Leukaemia) Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Respiratory/Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Skin Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Other Cancers Consumption and Growth Rate (2017-2022)

    • Figure Global Radiation Oncology Consumption by Country (2017-2022)

    • Table North America Radiation Oncology Consumption by Country (2017-2022)

    • Figure United States Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Canada Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Mexico Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Table Europe Radiation Oncology Consumption by Country (2017-2022)

    • Figure Germany Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure UK Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Spain Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Belgium Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure France Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Italy Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Denmark Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Finland Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Norway Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Sweden Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Poland Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Russia Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Turkey Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Table APAC Radiation Oncology Consumption by Country (2017-2022)

    • Figure China Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Japan Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure India Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure South Korea Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Thailand Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Singapore Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Philippines Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Table South America Radiation Oncology Consumption by Country (2017-2022)

    • Figure Brazil Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Colombia Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Chile Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Argentina Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Peru Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Table GCC Radiation Oncology Consumption by Country (2017-2022)

    • Figure Bahrain Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Oman Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Qatar Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Table Africa Radiation Oncology Consumption by Country (2017-2022)

    • Figure Nigeria Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure South Africa Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Egypt Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure Algeria Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Table Oceania Radiation Oncology Consumption by Country (2017-2022)

    • Figure Australia Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Radiation Oncology Consumption and Growth Rate (2017-2022)

    • Table C R Bard Company Details

    • Table C R Bard Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table C R Bard Radiation Oncology Main Business and Markets Served

    • Table C R Bard Radiation Oncology Product Portfolio

    • Table iCAD Company Details

    • Table iCAD Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table iCAD Radiation Oncology Main Business and Markets Served

    • Table iCAD Radiation Oncology Product Portfolio

    • Table Nordion Company Details

    • Table Nordion Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nordion Radiation Oncology Main Business and Markets Served

    • Table Nordion Radiation Oncology Product Portfolio

    • Table Mevion Medical Systems Company Details

    • Table Mevion Medical Systems Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mevion Medical Systems Radiation Oncology Main Business and Markets Served

    • Table Mevion Medical Systems Radiation Oncology Product Portfolio

    • Table Toshiba Medical Systems Company Details

    • Table Toshiba Medical Systems Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Toshiba Medical Systems Radiation Oncology Main Business and Markets Served

    • Table Toshiba Medical Systems Radiation Oncology Product Portfolio

    • Table Varian Medical Systems Company Details

    • Table Varian Medical Systems Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Varian Medical Systems Radiation Oncology Main Business and Markets Served

    • Table Varian Medical Systems Radiation Oncology Product Portfolio

    • Table NTP Radioisotopes Company Details

    • Table NTP Radioisotopes Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table NTP Radioisotopes Radiation Oncology Main Business and Markets Served

    • Table NTP Radioisotopes Radiation Oncology Product Portfolio

    • Table Accuray Company Details

    • Table Accuray Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Accuray Radiation Oncology Main Business and Markets Served

    • Table Accuray Radiation Oncology Product Portfolio

    • Table IBA Worldwide Company Details

    • Table IBA Worldwide Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table IBA Worldwide Radiation Oncology Main Business and Markets Served

    • Table IBA Worldwide Radiation Oncology Product Portfolio

    • Table IsoRay Company Details

    • Table IsoRay Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table IsoRay Radiation Oncology Main Business and Markets Served

    • Table IsoRay Radiation Oncology Product Portfolio

    • Table Elekta Company Details

    • Table Elekta Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Elekta Radiation Oncology Main Business and Markets Served

    • Table Elekta Radiation Oncology Product Portfolio

    • Table Carl Zeiss Meditec Company Details

    • Table Carl Zeiss Meditec Radiation Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Carl Zeiss Meditec Radiation Oncology Main Business and Markets Served

    • Table Carl Zeiss Meditec Radiation Oncology Product Portfolio

    • Figure Global External Beam Radiation Therapy (EBRT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Brachytherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Cancer (Leukaemia) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Respiratory/Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Skin Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Cancers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiation Oncology Consumption Forecast by Country (2022-2028)

    • Table North America Radiation Oncology Consumption Forecast by Country (2022-2028)

    • Figure United States Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Radiation Oncology Consumption Forecast by Country (2022-2028)

    • Figure Germany Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Radiation Oncology Consumption Forecast by Country (2022-2028)

    • Figure China Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Radiation Oncology Consumption Forecast by Country (2022-2028)

    • Figure Brazil Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Radiation Oncology Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Radiation Oncology Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Radiation Oncology Consumption Forecast by Country (2022-2028)

    • Figure Australia Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Radiation Oncology Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.